On the Call: Merck CEO Kenneth C. Frazier
Drugmaker Merck & Co., discussing its first-quarter results, said it will apply for approval by the end of 2013 for five new products, including a new type of drug to fight bone-thinning osteoporosis, odanacatib.
Join the discussion below, or Read more at CBS News.
#1 May 4, 2012
I think people can see this as justice especially of they are affected of the Fosamax situation because it should have been his duty as CEO to look over things in the company.
#3 Jul 13, 2012
Considering the things that came up with Fosamax and how they handles it, I am now very careful about using any Merck products especially the new ones. http://www.fosamaxfemurfracturelawsuit.com
#5 Aug 31, 2012
The new osteoporosis drug from Merck and Co. is indeed promising. However, as were any medication, there may be no full guarantee that the upcoming drug won't have reports of side effects. As with Fosamax, reports have adverse events are still piling up. For additional information visit http://www.fosamax-lawsuit.net
Add your comments below
|Can exercise improve back pain (Aug '13)||9 hr||ChattChiro||66|
|spinal cord stimulator removal (Apr '11)||Thu||dndollo||243|
|Spinal fusion 6months post op. Pressure feelin... (Dec '07)||Wed||Fmusician||170|
|spinal fusion complications (Jan '07)||Mar 21||spartan2123||709|
|Best Shiatsu Neck and Back massager with heat||Mar 13||Yube||1|
Find what you want!
Search Back Pain Forum Now
Copyright © 2017 Topix LLC